SC
ACOR

Saltoro Capital’s Acorda Therapeutics ACOR Stock Holding History

Saltoro Capital’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,570
Closed -$23.9K – 98
2023
Q1 		$23.9K Sell
2,570
-2,871
-53% -$47.7K 0.07% 48
2022
Q4 		$83.4K Hold
5,441
– – 0.27% 35
2022
Q3 		$33K Hold
5,441
– – 0.04% 41
2022
Q2 		$51K Buy
5,441
+4,699
+633% +$83.5K 0.08% 42
2022
Q1 		$24K Hold
742
– – 0.03% 76
2021
Q4 		$35K Buy
+742
New +$51.1K 0.03% 70
2021
Q3 		– Sell
-593
Closed -$57K – 154
2021
Q2 		$57K Buy
+593
New +$51.9K 0.06% 88

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $4.65B AUM 56.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return